The Relation Between Obesity and Mortality in Postcardiotomy Venoarterial Membrane Oxygenation.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
07 2023
Historique:
received: 24 10 2022
revised: 16 02 2023
accepted: 13 03 2023
medline: 26 6 2023
pubmed: 5 4 2023
entrez: 4 4 2023
Statut: ppublish

Résumé

Obesity is an important health problem in cardiac surgery and among patients requiring postcardiotomy venoarterial extracorporeal membrane oxygenation (V-A ECMO). Still, whether these patients are at risk for unfavorable outcomes after postcardiotomy V-A ECMO remains unclear. The current study evaluated the association between body mass index (BMI) and in-hospital outcomes in this setting. The Post-cardiotomy Extracorporeal Life Support (PELS-1) study is an international, multicenter study. Patients requiring postcardiotomy V-A ECMO in 36 centers from 16 countries between 2000 and 2020 were included. Patients were divided in 6 BMI categories (underweight, normal weight, overweight, class I, class II, and class III obesity) according to international recommendations. Primary outcome was in-hospital mortality, and secondary outcomes included major adverse events. Mixed logistic regression models were applied to evaluate associations between BMI and mortality. The study cohort included 2046 patients (median age, 65 years; 838 women [41.0%]). In-hospital mortality was 60.3%, without statistically significant differences among BMI classes for in-hospital mortality (P = .225) or major adverse events (P = .126). The crude association between BMI and in-hospital mortality was not statistically significant after adjustment for comorbidities and intraoperative variables (class I: odds ratio [OR], 1.21; 95% CI, 0.88-1.65; class II: OR, 1.45; 95% CI, 0.86-2.45; class III: OR, 1.43; 95% CI, 0.62-3.33), which was confirmed in multiple sensitivity analyses. BMI is not associated to in-hospital outcomes after adjustment for confounders in patients undergoing postcardiotomy V-A ECMO. Therefore, BMI itself should not be incorporated in the risk stratification for postcardiotomy V-A ECMO.

Sections du résumé

BACKGROUND
Obesity is an important health problem in cardiac surgery and among patients requiring postcardiotomy venoarterial extracorporeal membrane oxygenation (V-A ECMO). Still, whether these patients are at risk for unfavorable outcomes after postcardiotomy V-A ECMO remains unclear. The current study evaluated the association between body mass index (BMI) and in-hospital outcomes in this setting.
METHODS
The Post-cardiotomy Extracorporeal Life Support (PELS-1) study is an international, multicenter study. Patients requiring postcardiotomy V-A ECMO in 36 centers from 16 countries between 2000 and 2020 were included. Patients were divided in 6 BMI categories (underweight, normal weight, overweight, class I, class II, and class III obesity) according to international recommendations. Primary outcome was in-hospital mortality, and secondary outcomes included major adverse events. Mixed logistic regression models were applied to evaluate associations between BMI and mortality.
RESULTS
The study cohort included 2046 patients (median age, 65 years; 838 women [41.0%]). In-hospital mortality was 60.3%, without statistically significant differences among BMI classes for in-hospital mortality (P = .225) or major adverse events (P = .126). The crude association between BMI and in-hospital mortality was not statistically significant after adjustment for comorbidities and intraoperative variables (class I: odds ratio [OR], 1.21; 95% CI, 0.88-1.65; class II: OR, 1.45; 95% CI, 0.86-2.45; class III: OR, 1.43; 95% CI, 0.62-3.33), which was confirmed in multiple sensitivity analyses.
CONCLUSIONS
BMI is not associated to in-hospital outcomes after adjustment for confounders in patients undergoing postcardiotomy V-A ECMO. Therefore, BMI itself should not be incorporated in the risk stratification for postcardiotomy V-A ECMO.

Identifiants

pubmed: 37015310
pii: S0003-4975(23)00353-3
doi: 10.1016/j.athoracsur.2023.03.025
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-154

Investigateurs

Justine Ravaux (J)
Michele di Mauro (M)
Ann-Kristin Schaefer (AK)
Luca Conci (L)
Philipp Szalkiewicz (P)
Jawad Khalil (J)
Sven Lehmann (S)
Jean-Francois Obadia (JF)
Nikolaos Kalampokas (N)
Erwan Flecher (E)
Dinis Dos Reis Miranda (DD)
Hergen Buscher (H)
Daniel Herr (D)
Nazli Vedadi (N)
Marco Di Eusanio (M)
Graeme Maclaren (G)
Ram Ramanathan (R)
Alessandro Costetti (A)
Chistof Schmid (C)
Roberto Castillo (R)
Vladimir Mikulenka (V)
Marco Solinas (M)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Samuel Heuts (S)

Department of Cardiothoracic Surgery, Maastricht University Medical Centre+ and Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands. Electronic address: sam.heuts@mumc.nl.

Silvia Mariani (S)

Department of Cardiothoracic Surgery, Maastricht University Medical Centre+ and Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands.

Bas C T van Bussel (BCT)

Department of Intensive Care Medicine and Care and Public Health Research Institute (CAPHRI), Maastricht, the Netherlands.

Udo Boeken (U)

Heinrich Heine University, Düsseldorf, Germany.

Robertas Samalavicius (R)

Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.

Karl Bounader (K)

Pontchaillou University Hospital, Rennes, France.

Xiaotong Hou (X)

Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Jeroen J H Bunge (JJH)

Erasmus MC, Rotterdam, the Netherlands.

Kogulan Sriranjan (K)

Centre of Applied Medical Research, St Vincent's Hospital, Darlinghurst, New South Wales, Australia; University of New South Wales, Sidney, New South Wales, Australia.

Dominik Wiedemann (D)

Medical University of Vienna, Vienna, Austria.

Diyar Saeed (D)

Leipzig Heart Centre, Leipzig, Germany.

Matteo Pozzi (M)

Louis Pradel Cardiologic Hospital, Lyon, France.

Antonio Loforte (A)

Istituto di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Leonardo Salazar (L)

Fundación Cardiovascular de Colombia, Bucaramanga, Colombia.

Bart Meyns (B)

Department of Cardiovascular Sciences, University Hospitals Leuven, University of Leuven, Leuven, Belgium.

Michael A Mazzeffi (MA)

University of Maryland, Baltimore, Maryland.

Sacha Matteucci (S)

Strutture Organizzative Dipartimentali Cardiochirurgia Ospedali Riuniti 'Umberto I-Lancisi-Salesi' Università Politecnica delle Marche, Ancona, Italy.

Sandro Sponga (S)

Cardiothoracic Department, University Hospital of Udine, Udine, Italy.

Vitaly Sorokin (V)

National University Heart Centre, National University Hospital, Singapore, Singapore.

Claudio Russo (C)

Cardiac Thoracic and Vascular Department, Niguarda Hospital, Milan, Italy.

Francesco Formica (F)

San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy; Cardiac Surgery Unit, University Hospital of Parma, Parma, Italy.

Pranya Sakiyalak (P)

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Antonio Fiore (A)

University Hospital Henri-Mondor, Créteil, Paris, France.

Daniele Camboni (D)

University Medical Centre Regensburg, Regensburg, Germany.

Giuseppe Maria Raffa (GM)

IRCCS-ISMETT (Istituto di Ricovero e Cura a Carattere Scientifico-Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, Italy.

Rodrigo Diaz (R)

ECMO Unit, Departamento de Anestesia, Clínica Las Condes, Las Condes, Santiago, Chile.

I-Wen Wang (IW)

Memorial Healthcare System, Hollywood, Florida.

Jae-Seung Jung (JS)

Korea University College of Medicine, Seoul, South Korea.

Jan Belohlavek (J)

General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.

Vin Pellegrino (V)

The Alfred Hospital, Melbourne, Victoria, Australia.

Giacomo Bianchi (G)

Ospedale del Cuore Fondazione Toscana "G. Monasterio," Massa, Italy.

Matteo Pettinari (M)

Ziekenhuis Oost-Limburg, Genk, Belgium.

Alessandro Barbone (A)

Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Rozzano, Milan, Italy.

José P Garcia (JP)

Indiana University Methodist Hospital, Indianapolis, Indiana.

Kiran Shekar (K)

The Prince Charles Hospital, Brisbane, Queensland, Australia.

Glenn Whitman (G)

Johns Hopkins Hospital, Baltimore, Maryland.

Roberto Lorusso (R)

Department of Cardiothoracic Surgery, Maastricht University Medical Centre+ and Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH